Tag Marcus Schindler

Company News, News

Novo Nordisk has entered into separate research collaborations with Omega and Cellarity.

Novo Nordisk has entered into separate research collaborations with Omega and Cellarity. The Omega collaboration will leverage its proprietary platform technology to develop an epigenomic controller designed to enhance metabolic activity. The Cellarity collaboration aims to unravel novel biological drivers…

January 4, 2024

Company News, News, Statements

Valo Health and Novo Nordisk collaborate to discover novel treatments for cardiometabolic diseases using human data and AI.

Bagsværd, Denmark and Boston, Massachusetts, US, 25 September 2023 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation…

September 25, 2023